Hematologic and laboratory parameters in patientis with peptic ulcer bleeding treated by two modalities of endoscopic haemostasis and proton pompe inhibitors
Aim To compare two schedules (continuous infusion or bolus iv. ofPPI) in treatment after endoscopic homeostasis of bleeding ulcers. Methods Patients with gastrointestinal bleeding caused by peptic ulcer, or a recent history (<24 h before presentation) were included in the study. All cases with ac...
Main Authors: | Amila Mehmedović-Redžepović, Rusmir Mesihović, Besim Prnjavorac, Aida Kulo, Kalajdžija Merlina |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Association of Zenica-Doboj Canton
2011-02-01
|
Series: | Medicinski Glasnik |
Subjects: | |
Online Access: | http://www.ljkzedo.com.ba/medglasnik/vol81/MGvol81.2011_29.pdf |
Similar Items
-
Endoscopic Hemostatic Treatment of Peptic Ulcer Bleeding
by: Yeon Hwa Choe, et al.
Published: (2018-12-01) -
Predictive factors for failure of endoscopic management therapy in peptic ulcer bleeding
by: Siva Radhakrishnan, et al.
Published: (2002-01-01) -
Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy
by: Yen Hsu-Heng, et al.
Published: (2012-06-01) -
Recent Developments in the Endoscopic Treatment of Patients with Peptic Ulcer Bleeding
by: Jae-Young Jang
Published: (2016-09-01) -
Characteristics of Pompe disease in China: a report from the Pompe registry
by: Yuying Zhao, et al.
Published: (2019-04-01)